HomeABOUT USIntroduction

未标题-1.jpg


Shanghai Miracogen Inc. is a Sino-US joint venture biotechnology company specializing in research, clinical development and commercialization of targeted cancer therapeutics, especially Antibody Drug Conjugates (ADCs).  The company was founded in early 2014 and is located in Shanghai Zhangjiang Hi-Tech Park with 1500 of office and lab space equipped with state of the art biopharmaceutical instruments.  We aim to bring safe, effective and affordable anti-cancer drugs to patients in China and the rest of the world.